[SOCRATES - アスピリンまたはチカグレロルで治療された急性脳卒中または一過性脳虚血発作と患者の転帰]

基本情報

NCT ID

NCT01994720

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

13,307

治験依頼者名

AstraZeneca

概要

The primary objective of the study is to compare the effect of 90-day treatment with ticagrelor (180 mg \[two 90 mg tablets\] loading dose on Day 1 followed by 90 mg twice daily maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300 mg \[three 100 mg tablets\] loading dose on Day 1 followed by 100 mg once daily maintenance dose for the remainder of the study) for the prevention of major vascular events (composite of stroke, myocardial infarction \[MI\], and death) in patients with acute ischaemic stroke or transient ischaemic attack (TIA).

対象疾患

介入

依頼者（Sponsor）